B. Braun Ceftazidime Duplex Container for Injection USP and Dextrose Injection USP (24/Case)

The B. Braun Duplex Container system offers highly convenient, pre-measured strengths of Ceftazidime for Injection USP, designed to simplify preparation and enhance medication safety.The available dosages are:* 1 Gram* 2 GramsBoth dosages are standardized for administration in a 50 mL volume of Dextrose Injection USP diluent.This ready-to-use format eliminates the need for complex mixing or manual reconstitution, reducing the risk of medication errors. Each case contains 24 individual duplex containers. The product also boasts a 24-month total shelf life and can be stored at room temperature, requiring no thawing.

The B. Braun Duplex Container features several advanced safeguards to protect patients, medication potency, and healthcare staff.

• Closed System Integrity: The two-compartment design maintains a closed system that prevents external contamination and protects medication efficacy. This design also safeguards staff by protecting against exposure to airborne cephalosporins.
• Enhanced Medication Safety: It significantly reduces mixing errors because the system is designed so the diluent (Dextrose Injection USP) cannot be administered without the Ceftazidime medication. This ready-to-use format eliminates complex manual preparation.
• Material and Environmental Safety: The container is manufactured without latex, PVC, or DEHP, minimizing potential patient risks. Furthermore, its composition prevents the release of harmful dioxins during disposal.
• Compliance and Traceability: This system adheres to strict regulatory standards, meeting both Joint Commission and USP 797 guidelines. Additionally, the integrated barcode references the final admixture, aiding in correct drug identification and automated charting.

The B. Braun Ceftazidime Duplex Container is a ready-to-use system designed for simple, immediate activation, often at the patient’s bedside. It eliminates the need for separate vials, complex mixing, or thawing.

To mix the components, simply fold and squeeze the bag to rupture the internal seal. This action instantly combines the two separate chambers:

• The drug component: Ceftazidime for Injection USP
• The diluent component: Dextrose Injection USP

The resulting standardized 50 mL admixture is prepared in a closed system, which ensures potency protection and prevents contamination prior to IV administration.

The total shelf life for the B. Braun Ceftazidime Duplex Container is 24 months.

A key convenience feature is that the container can be stored at room temperature, eliminating the need for thawing.

Each case contains 24 B. Braun Ceftazidime Duplex Containers.

Yes, the B. Braun Ceftazidime Duplex Container is fully compliant with stringent regulatory standards. It meets the requirements set forth by both:

• The Joint Commission
• USP 797 guidelines

Yes, the B. Braun Ceftazidime Duplex Container is specifically engineered to integrate seamlessly into modern hospital workflows, including automated dispensing systems.

This compatibility offers significant benefits for workflow and safety:

• System Integration: The container works efficiently in conjunction with automated dispensing equipment, streamlining pharmacy processes.
• Enhanced Safety and Traceability: An integrated barcode references the final drug admixture, which helps ensure correct drug identification and supports accurate, automated charting.
• Efficiency: The design simplifies labeling and dispensing protocols, contributing to reduced medication errors.

The standardized delivery volume for the B. Braun Ceftazidime Duplex Container is 50 mL.

This delivery size is consistent for both available drug concentrations, applying equally to the 1 Gram and 2 Gram dosing configurations. This standardization is designed to support efficient and consistent administration in clinical settings.

Yes, the B. Braun Ceftazidime Duplex Container utilizes a closed system design. This feature is crucial for maintaining medication integrity and enhancing safety for both patients and healthcare providers.

Key advantages of the closed system include:

• Enhanced Safety: The design prevents mixing errors; the diluent cannot be administered without the drug component being present.
• Contamination Prevention: It prevents external contamination, ensuring the pre-measured drug and diluent remain sterile until immediately prior to use.
• Potency Protection: The closed environment protects the medication’s efficacy and allows for a long 24-month shelf life at room temperature without requiring thawing.
• Compliance: This system meets stringent industry standards, including the Joint Commission and USP 797 guidelines.
• Personnel Protection: It helps protect staff by guarding against exposure to airborne cephalosporins.

Yes, the B. Braun Duplex container is manufactured using materials that prioritize patient safety and environmental stewardship. The container is intentionally made without latex, PVC, or DEHP.

This composition not only minimizes patient risk but also prevents the release of harmful dioxins during product disposal.